FORZINITY (ELAMIPRETIDE HCI) INJECTION
Live / Allowed — Notice of allowance issued (as of 17 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Mar 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99087371
- Mark type
- Design + words
- Filed
- 17 Mar 2025
- Published for opposition
- 23 Dec 2025
- Attorney of record
- Tricia L. Schulz
Goods and services
- Class 005 — Pharmaceuticals: Biopharmaceutical preparations for the treatment of mitochondrial, cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders; Pharmaceutical preparations for the prevention of mitochondrial, cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders; Biological preparations for the treatment of cellular abnormalities.
Owner
- STEALTH BIOTHERAPEUTICS INC., Needham, MA, US
- STEALTH BIOTHERAPEUTICS INC., Needham, MA, US
Prosecution history
- 30 Mar 2026 — POST PUBLICATION AMENDMENT – NOT ENTERED
- 27 Mar 2026 — ASSIGNED TO PETITION STAFF
- 17 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Jan 2026 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 23 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Dec 2025 — PUBLISHED FOR OPPOSITION
- 17 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Nov 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 19 Sept 2025 — NON-FINAL ACTION E-MAILED
- 19 Sept 2025 — NON-FINAL ACTION WRITTEN
- 15 Aug 2025 — ASSIGNED TO EXAMINER